The announcement follows the launch of AxisBiotix-PsTM in Spain, after prior authorisation was received in March
SkinBioTherapeutics, a life science business focused on skin health, has announced that it has received approval from regulators to issue AxisBiotix-Ps, a food supplement to alleviate the symptoms associated with psoriasis, into the Italian market.
The announcement follows the launch of AxisBiotix-PsTM in Spain, after prior authorisation was received in March. Building on the initial launch in the UK where customer retention rates have remained above 80%, the launch of AxisBiotix-Ps into another European market is the continuation in the commercialisation strategy.
Between 2-3% of Italians report being affected by psoriasis, in keeping with the global prevalence rate and similar to the rates reported in Spain and the UK, where AxisBiotix-PsTM is currently available. The fact that over half of Italians use food supplements to improve their overall health and wellbeing gives the Company confidence that the introduction of the product to the Italian market will be met positively.
The next target country for launch is France. Talks with French regulators are currently underway and commercialisation is anticipated in H2 2023.
Stuart J. Ashman, CEO of SkinBioTherapeutics, said: “In line with our strategic plan, we are delighted that AxisBiotix-Ps is now approved for sale into another European market, after the initial success in the UK and then Spain. We have seen high customer retention rates and we anticipate that Italian consumers will follow this trend due to their positive attitude to food supplements. We are now awaiting the decision from the regulatory authorities in France, which is on track for later in 2023.”
Psoriasis is a lifelong condition, with no known cure, which impacts the everyday lives of sufferers. Existing treatments such as steroids or immuno-suppressants cannot be used over the long-term, which makes AxisBiotix-Ps an effective solution to alleviate its symptoms. As a food supplement, AxisBiotix-Ps is based on strong scientific data regarding the gut-skin axis, re-introducing missing bacteria into the gut and redressing the balance to improve skin health.